propranolol has been researched along with Acute Onset Vascular Dementia in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, Y | 1 |
| Zhou, Q | 1 |
| Zhang, T | 1 |
| Li, Z | 1 |
| Chen, YP | 1 |
| Zhang, P | 1 |
| Yu, YF | 1 |
| Geng, H | 1 |
| Tian, YJ | 1 |
| Zhang, C | 1 |
| Wang, Y | 1 |
| Chen, JW | 1 |
| Chen, Y | 1 |
| Luo, HB | 1 |
1 other study available for propranolol and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Binding Sites; Catalytic Domain; | 2019 |